research
facil
fort
detrick
frederick
maryland
coordin
facilit
preclin
research
infecti
diseas
develop
medic
countermeasur
highconsequ
pathogen
facil
uniqu
maximum
contain
laboratori
world
convent
molecular
medic
imag
equip
incorpor
design
facil
capabl
provid
investig
uniqu
tool
dissect
diseas
pathogenesi
evalu
abil
anim
model
recapitul
human
diseas
test
candid
countermeasur
importantli
advanc
molecular
imag
potenti
provid
altern
endpoint
lethal
use
altern
endpoint
investig
reduc
number
anim
use
experi
evalu
countermeasur
subleth
model
incorpor
medic
imag
modal
clinic
laboratori
model
exist
hospit
highli
train
veterinari
medicin
team
irffrederick
uniqu
suit
advanc
understand
emerg
infecti
diseas
facilit
develop
medic
countermeasur
clinic
care
paradigm
previous
consid
imposs
integr
research
facil
irf
encompass
ft
support
scientif
research
biosafeti
level
bsl
pathogen
facil
ft
laboratori
space
includ
ft
bslanim
laboratori
ft
laboratori
space
irffrederick
six
core
laboratori
group
support
scientif
studi
undertaken
within
facil
includ
clinic
core
anatom
patholog
cell
cultur
medic
imag
compar
medicin
aerobiolog
core
group
contribut
integr
evalu
diseas
progress
experiment
infect
anim
facil
conceiv
wealth
phenotyp
empir
data
accumul
character
infect
howev
mani
recent
develop
clinic
tool
yet
appli
studi
highconsequ
pathogen
thu
result
mani
previou
anim
challeng
studi
convey
imprecis
understand
mechan
pathogenesi
emerg
pathogen
facilit
medic
countermeasur
mcm
develop
anim
model
must
close
recapitul
human
diseas
thu
irf
design
incorpor
standard
featur
seen
laboratori
also
stateoftheart
clinic
equip
includ
medic
imag
capabl
expect
increas
understand
diseas
process
associ
highconsequ
pathogen
facilit
develop
mcm
manag
option
primari
mission
irf
foster
collabor
broad
spectrum
eid
bd
research
commun
relationship
irf
collabor
organ
base
scope
research
relev
uniqu
capabl
irf
irf
collabor
fall
two
categori
fund
research
irf
stipul
resourc
nonstipul
irf
research
distinct
import
affect
collabor
research
contractu
step
plan
base
fund
mechan
collabor
negoti
agreement
establish
project
grant
memorandum
understand
mou
inter
agenc
agreement
iaa
collabor
agreement
ensur
parti
role
respons
clearli
outlin
irf
establish
process
support
set
research
agenda
identif
review
suitabl
project
extramur
research
collabor
approv
grant
includ
sign
letter
support
director
irf
well
request
applic
rfa
stipul
use
irf
alreadi
undergon
extens
nih
approv
process
therefor
requir
review
irf
scientif
steer
committe
research
within
categori
goe
directli
irf
priorit
resourc
alloc
oper
plan
research
project
requir
scientif
steer
committe
review
committe
ensur
fair
equit
review
nih
intramur
divis
director
extern
advisor
committe
make
recommend
irf
director
base
qualifi
research
paramet
relev
niaid
dcr
irf
mission
requir
uniqu
capabl
irf
abil
advanc
irf
capabl
support
cuttingedg
infecti
diseas
research
relev
human
diseas
use
complex
biolog
system
answer
question
regard
diseas
pathogenesi
strategi
intervent
includ
antimicrobi
vaccin
countermeasur
use
surrog
system
test
clinic
hypothes
prioriti
given
propos
project
requir
medic
imag
involv
categori
viral
agent
requir
contain
eg
filovirus
arenavirus
henipavirus
howev
project
consid
base
avail
resourc
work
pathogen
commenc
immedi
cdc
select
agent
approv
anticip
earli
qualifi
investig
includ
intern
colleagu
welcom
particip
level
although
case
may
wish
defer
irf
staff
member
special
train
requir
work
laboratori
need
medic
imag
highconsequ
diseas
vivo
medic
imag
emerg
power
addit
convent
studi
viral
pathogenesi
treatment
except
xray
applic
medic
imag
modal
focus
specif
viral
infect
diseas
associ
pathogen
thu
far
imposs
use
techniqu
singl
photon
emiss
comput
tomographi
spect
positron
emiss
tomographi
pet
comput
tomographi
ct
magnet
reson
imag
mri
provid
uniqu
insight
diseas
pathogenesi
includ
inflamm
alter
system
vascular
function
coagul
tissu
damag
technolog
investig
chart
evolut
lesion
individu
anim
link
find
clinic
manifest
chang
laboratori
valu
indic
diseas
sever
investig
veterinarian
analyz
gener
data
real
time
alter
treatment
protocol
clinic
algorithm
adjust
improv
care
wellb
anim
also
begin
mimic
normal
care
practic
clinic
set
wealth
data
gener
experi
use
medic
imag
mi
experiment
infect
anim
facilit
scientif
regulatori
review
mcm
use
cfr
part
often
refer
food
drug
administr
anim
rule
food
drug
administr
depart
health
human
servic
rule
regul
expect
pathophysiolog
emerg
diseas
process
anim
model
reason
well
understood
recapitul
human
condit
demonstr
mcm
mitig
diseas
also
requir
usual
food
drug
administr
requir
demonstr
one
anim
speci
unless
model
singl
speci
demonstr
suffici
well
character
predict
therapeut
respons
case
second
speci
may
need
mi
potenti
refin
anim
model
precis
defin
faith
recapitul
human
diseas
also
demonstr
candid
mcm
prevent
mitig
diseas
highconsequ
pathogen
tradit
reduct
major
morbid
lethal
view
accept
readili
interpret
outcom
anim
efficaci
studi
endpoint
present
signific
challeng
best
avail
model
uniformli
lethal
diseas
sever
match
human
diseas
emerg
pathogen
result
investig
often
face
daunt
choic
use
larg
number
anim
adapt
pathogen
interest
lethal
anim
model
develop
model
use
genet
modifi
anim
definit
adapt
chang
natur
pathogen
rais
concern
regard
relev
human
pathogen
well
dualus
regulatori
concern
genet
alter
anim
may
offer
altern
express
delet
gene
interest
usual
fail
fulli
recapitul
diseas
follow
infect
gener
investig
concern
express
delet
gene
typic
result
alter
phenotyp
may
impact
interpret
result
model
avail
mi
open
potenti
identifi
use
altern
outcom
lieu
option
mi
modal
provid
opportun
noninvas
serial
measur
physiolog
process
diseas
develop
within
singl
subject
time
thu
modal
complement
convent
anim
studi
reli
serial
euthanasia
necropsi
describ
pathogenesi
mi
scientist
irf
alreadi
studi
develop
consolid
lung
nonhuman
primat
infect
middl
eastern
respiratori
syndrom
coronaviru
merscov
mi
scientist
abl
chart
develop
quantif
lung
lesion
fig
abil
critic
assess
potenti
countermeasur
mild
diseas
model
addit
use
medic
imag
also
potenti
reduc
number
anim
need
studi
compli
russel
burch
three
rs
refin
reduct
replac
use
anim
research
anim
research
instanc
longitudin
approach
may
increas
statist
power
need
assess
efficaci
investig
drug
treatment
decreas
total
anim
number
need
research
rudin
weissled
advanc
mi
capabl
irf
includ
mri
spect
ct
petct
realtim
fluoroscopi
diagnost
carm
xray
endoscopi
ultrasound
modal
bring
uniqu
capabl
address
varieti
question
relat
infecti
diseas
identif
diseas
lesion
patholog
eg
area
inflamm
track
infect
cell
mri
use
magnet
field
combin
puls
radiowav
energi
gener
imag
organ
structur
insid
subject
mr
imag
obtain
without
contrast
agent
exploit
endogen
sourc
contrast
exogen
potenti
harm
contrast
agent
requir
wide
varieti
mri
techniqu
avail
provid
flexibl
monitor
infecti
diseas
process
environ
instanc
number
mri
techniqu
develop
assess
vascular
permeabl
integr
bloodbrain
barrier
edema
format
addit
quantifi
vascular
permeabl
mri
could
potenti
use
track
cell
migrat
hoehn
et
al
viral
infect
mri
therefor
use
tool
follow
develop
endotheli
leakag
progress
viral
hemorrhag
fever
observ
realtim
immun
respons
visual
macrophag
migrat
postinocul
vivo
magnet
reson
spectroscopi
measur
chang
rel
amount
certain
metabolit
infect
tissu
interest
cours
infect
therapeut
intervent
ct
scan
use
xray
visual
intern
structur
subject
imag
taken
varieti
angl
gener
digit
crosssect
slice
combin
gener
threedimension
imag
ct
suitabl
morpholog
function
imag
eg
multiphas
perfus
scan
provid
attenu
correct
combin
pet
ct
anoth
techniqu
perform
function
imag
pet
scan
positronemit
radionuclid
tracer
probe
administ
subject
subject
imag
concentr
probe
tissu
measur
imag
probe
uptak
pet
overlaid
coregist
threedimension
imag
intern
structur
subject
ct
exampl
investig
interest
identifi
tissu
region
increas
metabol
indic
inflamm
increas
cellular
replic
fluorodeoxyglucos
ffdg
analog
glucos
administ
subject
cell
take
glucos
analog
probe
accumul
scintil
crystal
detector
measur
releas
photon
combin
ct
imag
analysi
investig
visual
quantit
area
inflamm
discret
anatom
locat
pet
present
use
irf
establish
tissu
distribut
antivir
drug
relationship
fig
ct
volumerend
imag
lung
nonhuman
primat
acquir
prior
intratrach
inocul
baselin
middl
eastern
respiratori
syndrom
coronaviru
day
postinocul
imag
segment
highlight
pulmonari
vasculatur
red
area
increas
consolid
yellow
plasma
tissu
level
effect
viral
infect
paramet
essenti
inform
requir
fda
efficaci
rule
petct
also
use
irf
studi
monkeypox
dyall
et
al
surrog
smallpox
show
develop
progress
diseas
morpholog
physiolog
addit
qualit
interpret
medic
imag
quantit
analysi
chang
morpholog
function
anim
anatomi
allow
statist
analysi
find
anim
model
vivo
similar
petct
spectct
combin
ct
imag
radioact
probe
tradit
spectct
often
use
cardiac
studi
often
consid
less
sensit
pet
spect
typic
use
need
widen
observ
period
look
chang
probe
distribut
time
recent
progress
iter
reconstruct
techniqu
improv
resolut
imag
gener
spect
howev
pet
remain
modal
choic
higher
resolut
need
avail
modal
increas
choic
probe
radiolabel
extend
rang
studi
possibl
imag
diseas
emerg
pathogen
final
irf
also
incorpor
diagnost
xray
equip
well
ultrasound
equip
imag
team
obtain
standard
radiograph
project
imag
realtim
fluoroscop
seri
inject
iodin
contrast
agent
scientist
staff
member
current
use
ultrasound
visual
lesion
well
guid
variou
medic
procedur
eg
detect
fluid
lung
lymph
node
size
biopsi
incorpor
use
mi
equip
maximum
contain
present
uniqu
set
challeng
architect
engin
safeti
offici
scientist
imag
equip
locat
insid
high
contain
subject
imag
devic
decontamin
procedur
may
increas
risk
damag
eg
caustic
etch
detector
progress
degrad
devic
wire
insul
corros
solder
point
gener
laboratori
area
decontamin
exposur
paraformaldehyd
ga
follow
ammonium
bicarbon
neutral
frequent
mainten
mi
equip
often
necessari
requir
servic
engin
enter
area
unten
option
two
option
consid
permit
safe
insert
infect
anim
bore
instrument
without
break
biocontain
barrier
one
option
place
anim
close
contain
tube
transport
posit
within
bore
instrument
howev
logist
maintain
ventil
anesthesia
anim
maintain
condit
insid
tube
seem
insurmount
altern
approach
reconfigur
equip
leav
bare
minimum
compon
within
laboratori
develop
extens
laboratori
protrud
bore
machin
uniqu
challeng
innov
address
de
kokmercado
et
al
place
bulk
imag
equip
outsid
suit
fig
highcontain
zone
extend
bore
imag
devic
use
transpar
biocontain
tube
made
polycarbon
resin
thermoplast
philip
bioshield
tm
north
ryde
australia
design
facilit
routin
mainten
delic
instrument
factorytrain
personnel
without
enter
environ
anim
insid
biocontain
tube
veterinari
care
team
access
anim
procedur
ensur
health
wellb
anim
photograph
hot
cold
side
spect
imag
room
present
fig
effect
use
mi
equip
anim
studi
staff
identifi
procur
larg
assort
special
equip
develop
new
protocol
practic
attempt
imag
anim
safe
contain
perhap
appreci
challeng
abil
maintain
function
anesthet
anim
respir
rate
heart
rate
rhythm
oxygen
satur
blood
pressur
core
temperatur
mi
procedur
ensur
staff
safeti
maintain
function
advanc
life
support
includ
multiparamet
patient
monitor
eg
electrocardiographi
forc
air
warm
blanket
put
place
addit
inhal
anesthesia
equip
mechan
ventil
respirationcompromis
anim
breath
hold
requir
imag
use
throughout
facil
staff
train
use
equip
demonstr
profici
experi
live
infecti
agent
perform
safeti
featur
protocol
commun
protocol
also
institut
throughout
facil
importantli
equip
includ
encapsul
person
protect
suit
evalu
determin
mr
compat
contain
metal
current
staff
evalu
suitabl
telemetri
implant
mi
studi
camera
wireless
commun
system
veterinari
medicin
personnel
also
develop
implement
commun
imag
team
outsid
contain
visual
oper
anim
bore
contain
tube
fig
imag
suit
separ
two
side
hot
side
pathogen
present
pink
room
cold
side
without
pathogen
blue
room
biocontain
tube
polycarbon
resin
thermoplast
extend
hot
side
imag
suit
bore
imag
modal
cold
side
protocol
repres
exampl
myriad
procedur
practic
develop
de
novo
facil
execut
anim
studi
use
mi
complex
endeavor
requir
close
coordin
core
team
activ
clinic
patholog
core
provid
technic
support
investig
collabor
dnarna
highthroughput
extract
valid
quantit
realtim
polymeras
chain
reaction
qrtpcr
assay
dnaprotein
microarray
analysi
immunophenotypingflow
cytometri
cell
sort
cytokin
profil
immunofluoresc
analysi
uniqu
irf
incorpor
robot
mani
process
includ
dnarna
extract
viral
plaqu
assay
microneutr
assay
plaqu
reduct
neutral
test
enzymelink
immunosorb
assay
sampl
registr
via
barcod
highthroughput
clinic
patholog
procedur
highthroughput
flow
cytometri
analysi
clinic
support
provid
investig
throughout
diseas
studi
includ
anim
prescreen
addit
group
also
respons
maintain
central
viral
repositori
inventori
irffrederick
anatom
patholog
core
apc
perform
necropsi
histopatholog
wide
varieti
specialti
pathologybas
disciplin
clinic
patholog
electron
microscopi
immunopatholog
apc
laboratori
includ
two
stateoftheart
necropsi
suit
fullservic
histopatholog
electron
microscopi
laboratori
patholog
core
laboratori
offer
investig
realtim
gross
patholog
imag
postmortem
tabl
grosstissu
trim
station
histopatholog
servic
prepar
standard
hematoxylin
eosinstain
tissu
section
offer
special
histochem
stain
immunohistochem
stain
use
chromogen
fluoresc
dye
situ
hybrid
apc
staff
analyz
manual
andor
colorimetr
quantit
digit
imag
immunohistochem
stain
slide
perform
celltypespecif
molecular
quantit
analysi
nucleic
acid
protein
fullservic
transmiss
scan
electron
microscopi
laboratori
avail
ultrastructur
studi
includ
immunogold
label
individu
antibodi
epitop
vitro
cell
ex
vivo
tissu
section
compar
medicin
staff
irffrederick
provid
rapid
intervent
medic
anim
diseas
studi
veterinarian
work
close
boardcertifi
veterinari
pathologist
coordin
studi
inlif
portion
studi
vivarium
design
provid
proceduresupport
room
anim
room
limit
transport
anim
possibl
crosscontamin
space
larg
enough
contain
draft
tabl
anesthesia
equip
ventil
ultrasound
equip
endoscopybronchoscopi
direct
visual
collect
sampl
respiratori
gastrointestin
tract
minor
surgic
procedur
peripher
lymph
node
biopsi
tracheostomi
placement
central
venou
cathet
perform
procedur
room
staff
skill
perform
mani
sampl
method
includ
cystocentesi
steril
urin
collect
bronchoalveolar
lavag
bone
marrow
biopsi
aspir
cerebrospin
fluid
collect
anim
hous
design
accommod
indwel
chronic
catheter
studi
involv
constant
intraven
administr
therapeut
provid
support
care
intraven
fluid
medic
b
fig
repres
biocontain
strategi
imag
singl
photon
emiss
comput
tomographi
hot
side
imag
room
contain
subject
tabl
barrier
wall
separ
hot
side
cold
side
b
anim
insid
biocontain
tube
veterinari
care
team
access
anim
procedur
ensur
health
wellb
anim
design
subject
tabl
simplifi
facilit
decontamin
replac
part
scientist
highli
compromis
anim
studi
equip
steril
sanit
anim
studi
group
accomplish
autoclav
ethylen
oxid
ga
automat
scope
reprocessor
endoscopi
equip
final
core
compet
develop
irf
aerobiolog
irffrederick
aerobiolog
core
laboratori
analyz
impact
divers
hazard
biolog
infecti
aerosol
differ
region
deposit
inhal
dose
diseas
present
diseas
progress
aerosol
experiment
involv
highconsequ
pathogen
perform
within
class
iii
biosafeti
cabinet
insid
anim
cabinet
laboratori
use
biaera
technolog
autom
aerosol
manag
platform
describ
previous
lackemey
et
al
us
nation
academi
scienc
committe
anim
model
assess
countermeasur
bioterror
agent
recent
evalu
progress
anim
model
develop
refin
highconsequ
infecti
diseas
korch
et
al
addit
three
rs
committe
stress
import
use
method
develop
anim
model
transfer
cultur
good
laboratori
practic
develop
mcm
past
mani
investig
reli
similar
phenotyp
present
diseas
anim
compar
human
rather
similar
underli
molecular
mechan
diseas
reli
phenotyp
similar
assum
absolut
conserv
molecular
process
close
relat
anim
differ
speci
investig
rais
doubt
abil
exist
anim
model
accur
recapitul
human
diseas
predict
efficaci
candid
therapeut
human
seok
et
al
addit
scientif
fund
regulatori
commun
realiz
one
anim
model
may
recapitul
aspect
diseas
expect
uniform
near
uniform
lethal
pathogen
challeng
neither
reason
case
appropri
result
use
altern
endpoint
besid
lethal
investig
evalu
mcm
nonleth
model
rather
forc
diseas
cours
sever
human
condit
incorpor
medic
imag
modal
clinic
laboratori
model
exist
hospit
highli
train
veterinari
medicin
team
make
irffrederick
uniqu
suit
address
recommend
nation
academi
scienc
data
gener
experi
advanc
understand
emerg
diseas
advanc
develop
countermeasur
clinic
care
paradigm
previous
consid
imposs
